Kazuki Sudo

3.2k citations
131 papers · 2.4k · 1 hit paper · h-index 27

Impact in

    • MicroRNA in disease regulation
    • Cancer Genomics and Diagnostics
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

    • Cancer Genomics and Diagnostics 10
    • Breast Cancer Treatment Studies 10
    • Cancer Immunotherapy and Biomarkers 11

Kazuki Sudo

121 papers receiving 2.4k citations

Kazuki Sudo's Hit Papers

Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study 2023 · 79 citations
790+1+2Years since publication255075

Peers

Kazuki Sudo
Comparison fields: 5 of 88
  • Cancer Research 309
  • Oncology 467
  • Surgery 643
  • Pulmonary and Respiratory Medicine 314
  • Cell Biology 124
Replace Li‐Yu Lee with:
Li‐Yu Lee Taiwan
Elli E. Ioachim Greece
Imran Ahmad United Kingdom
Michael O. Idowu United States
Peggy Dartigues France
Chun‐Te Wu Taiwan
Cheng Ean Chee Singapore
Xiao-Shun He China
Qingxia Fan China
Jianmin Xu China
Kazuki Sudo relative to Li‐Yu Lee Taiwan Li‐Yu Lee's profile →
Citations per field
00.5×2×3.0×
Li‐Yu Lee · 1×
Citations per year

Countries citing papers authored by Kazuki Sudo

Since Specialization
Citations

This map shows the geographic impact of Kazuki Sudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuki Sudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuki Sudo more than expected).

Fields of papers citing papers by Kazuki Sudo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuki Sudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuki Sudo. The network helps show where Kazuki Sudo may publish in the future.

Co-authors

The 25 scholars most cited alongside Kazuki Sudo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kazuki Sudo Line = papers co-authored together Kazuki Sudo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014234
2 2013157
3 2013101
4 201392
5 201288
6 201788
7 201485
8
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study
Hit paper breakdown →
202379
9 201769
10 201362
11 201662
12 201956
13 201349
14 201449
15 201839
16
Gastric- and intestinal-type properties of human gastric cancers transplanted into nude mice.
198437
17 202136
18 201333
19 201533
20 202233

About Kazuki Sudo

Kazuki Sudo is a scholar working on Cancer Research, Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine and Surgery, having authored 131 papers that have together received 2.4k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (18 papers), Ovarian cancer diagnosis and treatment (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Cancer Genomics and Diagnostics (10 papers), Breast Cancer Treatment Studies (10 papers), Sarcoma Diagnosis and Treatment (9 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Gastric Cancer Management and Outcomes (8 papers). The work is most often cited by research in Cancer Research (309 citations), Oncology (467 citations), Surgery (643 citations), Pulmonary and Respiratory Medicine (314 citations) and Cell Biology (124 citations). Kazuki Sudo has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Jaffer A. Ajani, Roopma Wadhwa, Wayne Lewis Hofstetter, Hisashi Onodera, Takashi Taketa, Dipen Maheshbhai Maru, Seiji Ohigashi, Brian R. Weston, Daiki Kobayashi and Takuya Takahashi. Their work appears in journals such as Annals of Oncology, Oncology, Japanese Journal of Clinical Oncology, BMC Cancer and Cancer Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact